Camylofin

CAS No. 54-30-8

Camylofin( —— )

Catalog No. M14946 CAS No. 54-30-8

Camylofin is an antimuscarinic, is a smooth muscle relaxant.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 45 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Camylofin
  • Note
    Research use only, not for human use.
  • Brief Description
    Camylofin is an antimuscarinic, is a smooth muscle relaxant.
  • Description
    Camylofin is an antimuscarinic, is a smooth muscle relaxant.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    54-30-8
  • Formula Weight
    393.4
  • Molecular Formula
    C19H32N2O2·2ClH
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    Cl.Cl.CCN(CC)CCNC(C(=O)OCCC(C)C)C1=CC=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Dubey R, et al. J Drug Target. 2010 Sep;18(8):589-60
molnova catalog
related products
  • Merbromin

    Merbromin is a topical antiseptic used for minor cuts and scrapes.

  • Atrial natriuretic f...

    Atrial Natriuretic Peptide (ANP) (1-28),rat (TFA) is the main circulating forms of Atrial Natriuretic Peptide (ANP) in rats, which strongly inhibit the secretion of Ang II - stimulated endothelin-1.

  • L-Ascorbic Acid 2-Ph...

    L-ascorbic acid 2-phosphate (2-Phospho-L-ascorbic acid) magnesium hydrate is a long-acting vitamin C derivative that can stimulate collagen formation and expression. L-ascorbic acid 2-phosphate magnesium hydrate can be used as a culture medium supplement for the osteogenic differentiation of human adipose stem cells (hASCs). L-ascorbic acid 2-phosphate magnesium hydrate increases alkaline phosphatase (ALP) activity and expression of runx2A in hASCs during the osteogenic differentiation.